Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
PUT
iShares US Medical Devices ETF
IHI
$3.32B
| $212K | ﹤0.01% |
+8,400
| New | +$204K |
|
4177
Manhattan Associates
MANH
$11.1B
| $212K | ﹤0.01% |
4,089
-31,223
| -88% | -$1.57M |
|
|
APU
4178
CALL
DELISTED
AmeriGas Partners, L.P.
APU
| $212K | ﹤0.01% |
4,500
-3,400
| -43% | -$161K |
|
|
MB
4179
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $212K | ﹤0.01% |
7,728
+7,603
| +6,082% | +$196K |
|
|
PGEM
4180
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $212K | ﹤0.01% |
10,737
+8,665
| +418% | +$152K |
|
4181
Artivion
AORT
$1.27B
| $211K | ﹤0.01% |
12,659
+8,454
| +201% | +$149K |
|
4182
American Vanguard Corp
AVD
$72.1M
| $211K | ﹤0.01% |
12,702
-8,824
| -41% | -$147K |
|
|
CALY
4183
Callaway Golf Company
CALY
$3.45B
| $211K | ﹤0.01% |
19,043
-41,180
| -68% | -$451K |
|
4184
PUT
Xylem
XYL
$28.5B
| $211K | ﹤0.01% |
4,200
+400
| +11% | +$19.5K |
|
|
ECOL
4185
DELISTED
US Ecology, Inc.
ECOL
| $211K | ﹤0.01% |
4,509
+4,145
| +1,139% | +$207K |
|
|
SHLM
4186
DELISTED
Schulman (A.) Inc
SHLM
| $211K | ﹤0.01% |
6,715
+1,313
| +24% | +$43.6K |
|
|
NORD
4187
DELISTED
Nord Anglia Education, Inc.
NORD
| $211K | ﹤0.01% |
8,310
+7,278
| +705% | +$170K |
|
4188
CALL
AES
AES
$10.5B
| $210K | ﹤0.01% |
18,800
+10,200
| +119% | +$117K |
|
4189
iShares Gold Trust
IAU
$66B
| $210K | ﹤0.01% |
8,743
+1,250
| +17% | +$29.4K |
|
4190
iShares S&P 100 ETF
OEF
$20.5B
| $210K | ﹤0.01% |
2,011
+1,950
| +3,197% | +$201K |
|
4191
CALL
Sempra
SRE
$55.1B
| $210K | ﹤0.01% |
3,800
| – | – |
|
|
KANG
4192
DELISTED
iKang Healthcare Group, Inc.
KANG
| $210K | ﹤0.01% |
14,377
+14,300
| +18,571% | +$235K |
|
|
PAY
4193
PUT
DELISTED
Verifone Systems Inc
PAY
| $210K | ﹤0.01% |
11,200
-14,800
| -57% | -$282K |
|
4194
PUT
Enbridge
ENB
$114B
| $209K | ﹤0.01% |
5,000
+3,600
| +257% | +$152K |
|
4195
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $209K | ﹤0.01% |
2,300
-2,600
| -53% | -$233K |
|
4196
PUT
Synopsys
SNPS
$77.2B
| $209K | ﹤0.01% |
2,900
-900
| -24% | -$60.2K |
|
4197
United Parks & Resorts
PRKS
$2.15B
| $209K | ﹤0.01% |
11,423
-130,009
| -92% | -$2.42M |
|
|
ZYNE
4198
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $209K | ﹤0.01% |
+10,400
| New | +$207K |
|
|
XOG
4199
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $209K | ﹤0.01% |
11,234
+6,743
| +150% | +$121K |
|
4200
BioCryst Pharmaceuticals
BCRX
$2.31B
| $208K | ﹤0.01% |
24,687
-37,777
| -60% | -$263K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.